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Abstract: The aim of this study was to investigate the impact of commercialized biological control 
agents (BCAs) against two major mycotoxigenic fungi in cereals, Fusarium graminearum and 
Fusarium verticillioides, which are trichothecene and fumonisin producers, respectively. With these 
objectives in mind, three commercial BCAs were selected with contrasting uses and microorganism 
types (T. asperellum, S. griseoviridis, P. oligandrum) and a culture medium was identified to develop 
an optimized dual culture bioassay method. Their comportment was examined in dual culture 
bioassay in vitro with both fusaria to determine growth and mycotoxin production kinetics. 
Antagonist activity and variable levels or patterns of mycotoxinogenesis inhibition were observed 
depending on the microorganism type of BCA or on the culture conditions (e.g., different nutritional 
sources), suggesting that contrasting biocontrol mechanisms are involved. S. griseoviridis leads to a 
growth inhibition zone where the pathogen mycelium structure is altered, suggesting the diffusion 
of antimicrobial compounds. In contrast, T. asperellum and P. oligandrum are able to grow faster than 
the pathogen. T. asperellum showed the capacity to degrade pathogenic mycelia, involving 
chitinolytic activities. In dual culture bioassay with F. graminearum, this BCA reduced the growth 
and mycotoxin concentration by 48% and 72%, respectively, and by 78% and 72% in dual culture 
bioassay against F. verticillioides. P. oligandrum progressed over the pathogen colony, suggesting a 
close type of interaction such as mycoparasitism, as confirmed by microscopic observation. In dual 
culture bioassay with F. graminearum, P. oligandrum reduced the growth and mycotoxin 
concentration by 79% and 93%, respectively. In the dual culture bioassay with F. verticillioides, P. 
oligandrum reduced the growth and mycotoxin concentration by 49% and 56%, respectively. In vitro 
dual culture bioassay with different culture media as well as the nutritional phenotyping of different 
microorganisms made it possible to explore the path of nutritional competition in order to explain 
part of the observed inhibition by BCAs.  
Keywords: antagonistic agents; in vitro dual culture bioassay; mycotoxins; nutritional competition 
Key Contribution: Complementary and integrative approaches to characterize the impact of three 
distinct commercial biocontrol agents on the pathogenic capacities of two mycotoxingenic fungi, 
including the monitoring of growth, spore production, mycotoxin production or nutritional profile.  
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1. Introduction 
Many plant pathogens endanger agriculture, particularly in cereal production. Some of these 
phytopathogens can produce mycotoxins and have multi-destructive effects through reducing the 
yield and nutritional properties of grain, and can also affect its health-related characteristics. Among 
mycotoxigenic fungi, the genus Fusarium is the most prevalent and represents a significant risk [1]. 
Mycotoxins are small toxic molecules resulting from the secondary metabolism of these fungi. 
Fusarium graminearum is able to produce deoxynivalenol (DON) and its derivatives 15 and 3-ADON. 
Fusarium verticillioides mainly produces fumonisins B1 and fumonisins B2 (FB1 and FB2). They are 
ubiquitous in agricultural production, and cereal crops are the primary source of consumer exposure 
to mycotoxins [2]. Mycotoxins are quite stable molecules which are very difficult to remove or 
degrade, and are found along the food chain while retaining their toxic properties. They can cause 
acute and chronic intoxication in both humans and animals depending on different factors (intake 
levels, duration of exposure, toxin type, mechanisms of action, metabolism, and defense mechanisms) 
[3]. The symptoms can be very variable depending on organisms considered, but can range from food 
poisoning or gastric-intestinal problems to suppression of the immune system, the induction of 
cancer, or death [4,5]. Sometimes the combination within trichothecenes/fumonisins or with other 
mycotoxins such as ochratoxins or aflatoxins can produce a synergistic toxic effect [6,7]. Given their 
high toxicity, DON and fumonisins have been regulated by the European Union and the maximum 
recommended levels of mycotoxins are 750 µg kg-1 and 1000 µg kg-1, respectively, for processed cereal 
intended for human consumption (Commission Regulation (EC) No 401/2006). Economically, these 
contaminants hamper international trade and significantly affect the world economy. Because their 
appearance can occur before or after harvesting, one of best ways to reduce the presence of mycotoxins in 
food and feed is to prevent their formation in the crop [8].  
Agricultural production is subject to a scissor effect with, on one hand, very evolutive climatic 
conditions that promote microbial development and, on the other hand, the political determination 
to reduce the use of phyto-chemical products. The adverse effects of plant protection products on 
environment and on human and animal health have encouraged the European Union to promote the 
search for alternative and environmentally friendly solutions such as integrated pest protection and 
the use of biological control agents (BCAs) [9]. Non-pathogenic, they can prevent or reduce the 
progression of these fungi through different mechanisms. These mechanisms are very diverse, direct 
or indirect, and can be used together or alone depending on the biocontrol agent. The main direct 
mechanisms may be related to antibiosis, competition, parasitism, or toxin biotransformation [10]. 
Antibiosis includes the production of secondary metabolites like antibiotics, cell wall-degrading 
enzymes, and molecules that can suppress growth or kill pathogens [11–13]. Competition can occur 
when two or more fungi are present simultaneously. Microorganisms can then enter into nutritional 
competition when they need the same essential nutrient, or into spatial competition when they 
occupy the same limited space [14,15]. Parasitism is a direct attack of pathogen by the BCA that will 
degrade or consume the pathogen host until it dies [16]. Some mechanisms can be indirect. 
Colonization of the plant by beneficial microorganisms can trigger local or systemic defensive 
responses, enhancing resistance against phytopathogens [17,18]. 
Although the production of mycotoxins by toxigenic pathogens is of economic importance, 
many studies do not take this into account when studying biological control strategies. These studies 
are then limited to the fungicidal or fungistatic effects of BCAs, while the effect of BCAs on mycotoxin 
production is often neglected [19]. Moreover, most studies on the biocontrol of other plant pathogens 
do not consider the potential presence of several mycotoxins simultaneously in the crop, nor the side 
effects of BCAs on the mycotoxigenic agents present. Despite more than 70 years of intensive research 
and some promising results, only a few BCAs are currently available on the market, and for Fusarium 
spp. for instance in Europe, only Pseudomonas chlororaphis and Pythium oligandrum are available, as the 
commercial products Cerall® (Belchim Crop Protection) and Polyversum® (Biopreparáty/De 
Sangosse), respectively. 
The lack of commercially available BCAs for mycotoxigenic fusaria may be due to numerous 
factors (unstable biocontrol efficacy under field conditions, strict storage and transport conditions for 
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BCAs, complexity of registration) and more importantly a lack of knowledge about biocontrol 
mechanisms [20], especially concerning mycotoxins . 
Indeed, a better understanding of the mechanisms that allow the biocontrol of pathogens, 
especially on marketed agents that have passed all the stages of formulation and registration, will 
make it possible to identify particularly effective mechanisms or biomarkers of mechanisms. This 
information could be used to optimize the use of existing BCAs but also to refine the selection of new 
BCAs.  
The ultimate goal of the present study was to characterize the impact of commercial biocontrol 
agent on life traits of mycotoxigenic fungi (growth and mycotoxinogenesis). Therefore, the objectives 
were (1) to develop optimal methods of dual culture bioassay, allowing the analysis of the interaction 
between pathogens and BCAs; (2) to identify effect of BCAs on growth and mycotoxins of Fusarium 
graminearum and Fusarium verticillioides; and (3) to propose a hypothesis on the modes of action of 
BCAs against mycotoxigenic pathogens. With these objectives in mind, three commercial BCAs were 
selected with contrasting uses and microorganism types (T. asperellum, S. griseoviridis, P. oligandrum) and studied 
with in vitro dual culture bioassay against F. graminearum and F. verticillioides with an optimized method 
promoting mycotoxin production. Variable levels of mycotoxinogenesis and growth reduction were observed 
depending on the microorganism type of BCAs or on the culture conditions (e.g., different nutritional sources), 
suggesting contrasting biocontrol mechanisms. Macroscopic and microscopic observation of interactions support 
this hypothesis, finding various structural formations of BCA. Nutritional phenotyping was used to detect the 
possibility of nutritional competition between microorganisms, and to identify the trophic requirements of BCAs.  
2. Results 
To permit the interaction between BCAs and pathogens during dual culture bioassay, the first 
step was to select appropriate media to allow the development of each microorganism’s pairing 
(BCA/pathogen). BCA/pathogen selection criteria and descriptions are presented in Section 5, 
Material and Methods. Then, to characterize this interaction on selected media, integrative 
approaches were used. Microscopic and macroscopic observations were undertaken to identify 
specific comportment of BCAs and their effects on Fusarium physiology. The BCA treatment’s impact 
on growth, global mycotoxins, and specific mycotoxin production kinetics of pathogens was 
analysed. Finally, the impact of differential nutritional resources during dual culture bioassay was 
analysed and linked with the nutrient profiling of all microorganisms. 
2.1. Comportments of Microorganisms and Culture Media Selection  
After 8 days of incubation, all microorganisms were able to grow on all different media, with 
the exception of Polyversum® (Poly), which was unable to grow on Czapeck agar (CZA) synthetic 
medium (Figure 1). Mycostop® (Myco), which has the most limited growth (area under the growth 
curve, AUGC < 1.85 × 102), was an excellent spore producer (spores > 3.85 × 103), especially on 
International Streptomyces Project Medium 2 (ISP2). Xedavir® (Xeda) was minimally affected by the 
culture medium variation. Polyversum® (Poly), the oomycete BCA, was characterized solely on 
growth capacity because oospore obtention was a long and complex process which is difficult to 
achieve, and to obtain oospores under these specific in vitro conditions. F. graminearum produced a 
low quantity of spores affected by medium variation. For both pathogens, global mycotoxin 
production was a very discriminant variable for medium selection. The culture media on which 
pathogens F. graminearum and F. verticillioides produced the most mycotoxins were respectively CZA 
and PDA.  
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Figure 1. Comportment of all micro-organisms (commercialized biological control agents (BCAs) and 
pathogens) on different media. Stars indicate the final selected medium for each microorganism. 
Myco: Mycostop®, Xeda: Xedavir®, Poly: Polyversum®. AUGC: area under the growth curve, PDA: 
potato dextrose agar, CZA: Czapeck agar, CYA: Czapeck yeast agar, CMA: corn meal agar, OMA: oat 
meal agar, MYA: malt yeast agar, ISP2: International Streptomyces Project Medium 2 (8 days at 25 °C). 
Levels of global mycotoxins are given as a sum of the mycotoxins from a pathogen chemotype 
(Fusarium graminearum: deoxynivalenol (DON) + 15ADON and Fusarium verticillioides: fumonisins B1 
(FB1) + fumonisins B2 (FB2)). 
In order to promote pathogen development and mycotoxin production during interaction, the 
selection of dual culture bioassay media was firstly based on the mycotoxin production capacity of 
pathogen (Table 1). Then, the ability of BCAs for growth on this medium was checked. To observe 
the differential capacity of BCAs to impact mycotoxigenic fungi, one common medium (CM) for each 
pathogen was selected: for F. graminearum–BCA dual culture bioassay CYA was chosen, and for F. 
verticillioides–BCA dual culture bioassay PDA was selected. Other interesting media which did not 
allow all BCAs to grow were assigned to a specific dual culture bioassay duo (SM), and were selected 
for their ability to promote mycotoxinogenesis. These selected culture media were used to test 
antagonist activity and allowed identification of the impact of BCAs on pathogenic growth and 
mycotoxin production. The use of different culture media enabled the characterization of the impact 
of nutrient resources on the dual culture bioassay of microorganisms. 
Table 1. Selected media for dual culture bioassay. CM: common medium for all BCAs confrontation 
of concerned pathogen; SM: Specific media for each BCA-pathogen confrontation of concerned 
pathogen. Myco: Mycostop®, Xeda: Xedavir®, Poly: Polyversum®. 
Selected Media for Dual Culture Bioassay (Pathogen–BCA) 
Pathogens F. Graminearum F. Verticillioides 
BCA CM SM CM SM 
Myco CYA CZA PDA CYA 
Xeda CYA CZA PDA MYA 
Poly CYA OMA PDA OMA 
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2.2. Macroscopic and Microscopic Interaction 
During the dual culture bioassay test, the macroscopic observation of plates (7 days after 
inoculation) revealed differential comportments between microorganisms (Figure 2). For both 
pathogens, mycelial development was limited by the presence of all BCAs compared to the control. 
Myco formed a very small colony related to pathogens, but an inhibition zone of pathogen growth 
was observed (especially in dual culture bioassay with F. verticillioides). With respect to pathogens, 
accumulation of pigment was observed in the dual culture bioassay zone (on the reverse side of Petri 
dish, not shown). The Xeda colony grew as fast as the pathogen and filled the free space in the Petri 
dish. Once again, accumulation of pathogenic pigment in the confrontation zone could be observed 
on the reverse side of Petri dishes. The Xeda colony could exude fine black droplets on its surface 
solely during confrontation. Poly was able to grow faster than the pathogen (especially faster than F. 
graminearum) and fill the free space in Petri dish. During co-culture, it was able to progress on both 
the pathogenic colony and inhibit the homogenous and natural pink pigmentation of F. graminearum 
completely.  
At the microscopic scale, F. graminearum alone produced rapidly long, dense, and straight 
hyphae, while F. verticillioides alone produced fine and extra fine lightly branched hyphae (Figure 2). 
With microscopic interactions between BCAs and pathogens photographed over time, many 
characteristic structures could be observed. Myco was able to cause anarchic ramifications of F. 
graminearum mycelia before contact (+72 h) and vesicle formation at the tip of pathogen hyphae when 
they were close (+96 h). Growth inhibition by Myco was clearly identified at the microscopic level in 
co-culture with F. verticillioides, with an early antigerminative action (+72 h) and a linear/regular 
growth inhibition after 96 h. Xeda induced deformation of F. graminearum mycelia, which could 
extend to the formation of loops after 96 h. The progression of this BCA face-to-face with F. 
verticillioides created a mechanical barrier that slowed the progression of the mycotoxigenic fungus. 
In the dual culture bioassays of both pathogens, Xeda caused a degradation of pathogenic mycelia in 
contact zones (+96 h). The co-culture F. graminearum–Polyversum showed dispersed contact 
structures. The BCA was able to pass through the mycelium of the pathogen, and induced formation 
of lysed wall hyphae. It adopted a completely different comportment in the dual culture bioassay 
against F. verticillioides and induced the transient formation of micro-vesicles at the extremity of 
pathogenic hyphae (between 24 and 72 h of dual culture bioassay). When it was close to the pathogen 
(+96 h), it deployed long mycelial filaments to colonize the environment. 
2.3. BCA Impact on Growth and Mycotoxin Production 
During the antagonistic in vitro test, the growth and the mycotoxin production of both 
pathogens in confrontation against the three BCAs were monitored over 12 days. Classic batch curves 
were obtained for pathogen growth and major mycotoxin production (latent phase, exponential 
phase, stationary phase). The area under growth/global mycotoxins curve (respectively AUGC and 
AURMC) was calculated (Figure 3). All BCA treatments impacted growth of F. graminearum, 
especially Xeda and Poly, causing growth reductions of respectively 48% and 79%.  
In addition to reducing the pathogens mycelial development, Xeda and Poly had a direct action 
on global DON production, with reductions in mycotoxin concentrations of 73% and 93% 
respectively. F. graminearum 15-ADON production was affected and complete inhibition of 15-ADON 
peak production (8 days after inoculation) was observed with all BCA treatments (see Figure A2).  
Dual culture bioassays with F. verticillioides showed a completely different response profile to BCAs. 
Even if the growth reduction of pathogen was significant face-to-face with Myco (24%), the specific 
production was lightly stimulated. It was mainly with the reduction of pathogen growth that Xeda 
restricted fumonisin production, with the most important inhibition levels (78%) among all BCA 
tested.  
In summary, Poly was more efficient in the F. graminearum dual culture bioassay and Xeda was 
more efficient in the F. verticillioides dual culture bioassay using common media (CM). 
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Figure 2. Macroscopic and microscopic interactions during pathogen–BCA dual culture bioassay. The 
F. graminearum and F. verticillioides control and confrontation plates respectively had CYA and PDA 
media (CM, 7 days after inoculation). The same media were used for the slide confrontation (+72/96 
h after inoculation) indicated at the top of the figure. Colors indicate the type of microorganisms, and 
letters indicate specific structures. Myco: Mycostop®, Xeda: Xedavir®, Poly: Polyversum®. 
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Figure 3. Comparative effects of BCA treatments on the evolution of pathogens. Dual culture 
bioassays for all BCAs against one pathogen were performed on common medium (CM). (A) F. 
graminearum, on CYA, in orange; (B) F. verticillioides, on PDA, in pink, for 12 days. Myco: Mycostop®, 
Xeda: Xedavir®, Poly: Polyversum®. Growth (pastel colors, bottom axis) and mycotoxin production 
levels (pastel colors, top axis) are expressed in the area under growth/global mycotoxin curves 
(respectively AUGC and AUGMC). Original kinetic curves are available in Figure A2. ANOVA test, 
Growth comparisons (a, b, c, d) and Mycotoxin comparisons (A, B, C). p-value < 0.05. FB1 + FB2 are 
represented together because the quantity of FB2 was not significant. 
Toxins 2020, 12, 152 8 of 22 
 
2.4. Impact of Media Variation on Pathogenic Factors during Dual Culture Bioassay (Pathogens–BCAs) 
Principal component analysis (PCA) analysis was performed in order to visualize global 
inhibition profiles of pathogens depending on BCA treatment, but also to assess the impact of culture 
medium on those inhibition profiles (Figure 4). For both biplots, the variables are well-projected and 
equivalently projected, and the two first components explained 90.7% and 94.8% of data distribution 
for F. graminearum (Figure 4A) and F. verticillioides (Figure 4B), respectively. The growth factor mainly 
contributed to Dim2, mycotoxin factors mainly contributed to Dim1, and all variables were in 
correlation. With all culture media combined, Myco and Control samples were regrouped in both 
graphs in the positive part of biplot. However, culture media influenced the separation of samples 
on CZA (F. graminearum control or confronted with Myco). Control samples were correlated with 
DON and 15-ADON factors, in contrast to Myco treatment samples, on the other side of Dim2. In the 
F. graminearum bi-plot (Figure 4A), Xeda and Poly samples are regrouped in the bottom-left quarter 
of graph, suggesting strong opposition to the studied pathogen factor. For the Poly-confronted 
samples, an increase of mycotoxin inhibition was observed in OMA, highlighting the important effect 
of culture media on dual culture bioassay, illustrated here for F. graminearum. Global antagonist 
activity of Xeda against F. graminearum in the CYA medium was higher than on CZA. On theF. 
verticillioides bi-plot (Figure 4B), these two BCAs (Xeda and Poly) caused the most antagonistic 
activity. However, against this pathogen, Xeda showed the strongest growth and mycotoxin 
inhibition. MYA-confronted samples were further from the specific mycotoxin production factor than 
PDA-confronted samples, indicating a higher specific mycotoxin reduction in this culture medium. 
Poly was able to inhibit pathogenic factors in both culture media, but with OMA the separation 
between control and confronted samples was greater, suggesting a stimulation of antagonistic 
capacities on this culture medium. 
2.5. Nutrient Profiling and Nutritional Competition 
Given the observed medium impact, nutrient profiling of all microorganisms was characterized 
using phenotype microarray, and a comparison between microorganisms was performed to identify 
potential nutritional competition. Along 138 h of incubation, a contrasting capacity to consume the 
different nutritional resources appeared. As shown in Figure 5, globally, two clusters of 
microorganisms can be distinguished based on the capacity to metabolize C sources (Figure 5A), with 
separate microorganisms in two clusters: one with Poly and F. graminearum, which were able to 
consume less C sources than others (high trophic requirements), and one including F. verticillioides, 
Xeda, and Myco, which could consume a broad range of C sources (low trophic requirements). Some 
C compounds strongly stimulated the growth of microorganisms, such as tyramine/glucose, N-
acetylglucosamine/sucrose, threonine/tartaric acid, glycerol/uridine, and proline/sucrose, 
respectively, for Myco, Xeda, Poly, F. graminearum, and F. verticillioides. Sucrose was therefore the 
carbohydrate allowing the strongest growth of two antagonistic microorganisms (Xeda and F. 
verticillioides). On other hand, threonine is a compound that is consumed only by the Poly BCA and 
inhibits the growth of other microorganisms, including the two mycotoxigenic pathogens. 
Concerning the aptitude of microorganisms to degrade nitrogen sources (Figure 5B), two different 
clusters were formed: one with of Poly, Xeda, and Myco, which were able to consume less N sources 
than others (specialized); and one including F. graminearum and F. verticillioides, which could consume 
a broad range of N sources (unspecialized). This clustering was in accordance with the type of 
microorganism (BCAs or pathogens), and Poly has a nitrogen consumption profile which is in 
complete contrast to the F. verticillioides profile. Some N nutrients increase the growth of particular 
microorganisms: histidine/lysine, uric acid/serine, xanthine/L-cysteine, uric acid/allantoin, and serine 
/L-pyroglutamic acid, respectively, for Myco, Xeda, Poly, F. graminearum, and F. verticillioides. 
Preferential nitrogen sources of Xeda were also the preferential nitrogen sources of the two 
pathogens.  
Nutrient consumption and the resulting growth capacity were difficult to relate to the 
synergistic effects that could be observed in the dual culture bioassay on complex synthetic media. 
Nevertheless, results show that Poly, because of its high trophic requirement, has more difficulty 
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consuming nutrients than pathogens. This observation is confirmed with regard to the major 
elements that comprised the culture media of the dual culture bioassay (the two CM pathogens PDA 
and CYA, and the SM BCAs OMA), even on OMA, where it showed very strong antagonistic 
capacities during dual culture bioassay. Xeda had better biocontrol activity against F. verticillioides on 
MYA (global mycotoxin inhibition), and against F. graminearum on CYA (growth and global 
mycotoxin inhibition). The MYA medium was composed of fructose and mannitol, which the 
pathogen/BCA duo can degrade in equivalent proportions. CYA medium contains sucrose and 
nitrate, two compounds for which Xeda has a stronger affinity than F. graminearum. 
 
Figure 4. Principal component analysis (PCA) bi-plot with respect to the growth and mycotoxin 
production data set (---) for the two considered pathogens, (A) F. graminearum and (B) F. verticillioides, 
obtained after BCA confrontation (indicated by colors) in different selected culture media (indicated 
by forms). Myco: Mycostop®, Xeda: Xedavir®, Poly: Polyversum®. 
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Figure 5. Growth induction of microorganisms during growth on 95 carbon sources (PM1) (A) or 95 
nitrogen sources (PM3) (B). Both panels show optical density measurements over a 138-h time course 
(i.e., area under the growth curves, AUGCs). Color keys of the heat map (from purple to yellow) are 
expressed for one nutrient in comparison with other microorganisms (row comparison). Micro-
organisms are indicated by colors at the end of each column. Myco: Mycostop®, Xeda: Xedavir®, Poly: 
Polyversum®. Major elements included in the composition of selected media are indicated by forms 
next to the concerned nutrient. Medium compositions are available in Figure A1. 
3. Discussion 
Based on the presented results, the development of dual culture bioassay methods and in 
particular the choice of culture media should be considered during in vitro studies between 
mycotoxigenic pathogens and BCAs. Globally, complex culture media selected for the affinity that 
the microorganisms have for them allow good growth of all microorganisms, with the exception of 
Poly which does not grow on CZA, a minimum medium. However, the mycotoxinogenesis of 
pathogens is strongly influenced by the type of media, as shown by our results and as widely reported 
in the literature [21,22]. A study conducted by Gardiner et al. [22] on the nutritional profile of F. 
graminearum identified the same type of profile, with preferential consumption of the same nutrient 
as in our results. It is therefore necessary to select culture media that will promote production of this 
mycotoxin in order to identify BCAs that will have a considerable impact even during high 
production. Most of the in vitro dual culture bioassays between pathogenic fungi and BCAs are 
performed on PDA [23,24], which does not stimulate the production of tricothecenes by F. 
graminearum. The use of two media per BCA/pathogen coupling allows the observation of whether 
nutritional conditions impact the inhibition caused by BCAs. The high mycotoxigenic capacity of the 
strains was verified. Many variations can be observed between the two pathogens. In natural 
conditions, they originate from different environments, as F. graminearum is isolated from wheat 
spikes while F. verticillioides is isolated from maize kernels. In addition, the pathogens produce 
distinct types of mycotoxins (trichothecene for F. graminearum and fumonisins for F. verticillioides) 
and their production levels are also different. According to the analyses that we performed on both 
pathogenic strains, the maximum production of fumonisin and trichothecene was about 5000 and 
15000 ng g-1 of media, respectively. Moreover, their colonization strategies are in contrast: F. 
graminearum grew rapidly while producing fewer spores, unlike F. verticillioides for which expansion 
was slower, but it compensated with a substantial production of spores, allowing it to colonize the 
environment in a comparable way. For these reasons, most of the analyses are carried out 
independently. 
In dual culture bioassay with pathogens, Myco did not have time to develop, which did not 
allow it to compete spatially with pathogens. The halos of inhibition and the absence of contact 
during the observation period as well as the deformation of the pathogenic hyphae of F. graminearum 
suggest the synthesis of diffusible antimicrobial compounds by the BCA. Actinomycetes, and 
particularly Streptomyces species, are well known for their production of a wide spectrum of 
antibiotics [25,26]. In dual culture bioassay with F. verticillioides, they were even able to remotely 
prevent germination of pathogenic spores and completely inhibit pathogen progression. Several 
compounds were emitted by Streptomyces spp. and identified (e.g., as methyl vinyl ketone) for their 
ability to inhibit the spore germination of phytopathogens [27,28]. The appearance of vesicles at the 
tips of the hyphae of F. graminearum may be related to the synthesis of mycotoxins. Some studies have 
found that mycotoxins, notably in F. graminearum, were synthesized in toxisomes, a kind of vesicle 
excreted out of the cells and at the tip of hyphae [29,30]. The pathogen’s perception of BCA may 
stimulate this production. Based on the results of the antagonistic tests, Myco tends to stimulate 
specific mycotoxin production despite significant inhibition of the growth of both pathogens. 
Therefore, it is essential to test the ability of BCAs to impact mycotoxin production and not only 
growth. Its ability to degrade many sources of C allows it to grow under many conditions, which 
could make it a preventive treatment. However, to effectively control pathogens, the ratio of 
inoculum from Myco must be superior than the quantity of pathogens.  
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Xedavir adopts a completely different strategy. With good colonization capacities, can compete 
with the development of pathogens. It can form a mechanical barrier that physically blocks the 
development of pathogenic fungi and is also be able to establish connections between its hyphae and 
those of pathogens through the formation of haustaurium [31]. When in contact with pathogens, it 
can also synthesize compounds that degrade the fungal walls, probably chitinases, preventing the 
progression of pathogens. Numerous studies have shown this ability in different species of 
Trichoderma [32,33]. Not surprisingly, the genomes of the mycoparasitic Trichoderma spp. are rich in 
gene-encoding enzymes like chitinases and glucanases [34,35]. This wall degradation will provide a 
preferential substrate for further development. It will rather have a hyperparasitic behavior [36]. Its 
goal is to kill pathogens. Faced with F. graminearum, it will act directly on the specific 
mycotoxinogenesis independently of growth reduction. It will therefore be able to act directly on the 
mycotoxin biosynthesis pathways, or by biotransformation of the mycotoxins produced 
(transformation, degradation, binding). It would be interesting to explore this potential because 
recent studies have identified mycotoxin degradation capacities in other BCAs of the Trichoderma 
genus [37]. During in vitro dual culture bioassays on selected media, culture media seem to influence 
the impact of Xeda on pathogens. The nutritional resources of microorganisms will therefore impact 
the inhibition of pathogens by BCAs. One culture medium could even allow Xeda to act more 
drastically on specific mycotoxinogenesis (MYA–F. verticillioides), and thus reduced the mycotoxin 
concentrations of samples. These results suggest that nutritional competition phenomena could be 
one of the weapons used by Xeda to fight pathogens. This path is supported by the comparison of 
nutritional profiles of Xeda and pathogen nutritional profiles. It appears that for certain compounds, 
the capacities of assimilation will be equivalent or to the advantage of BCAs, notably certain culture 
media compounds used during the dual culture bioassays (like sucrose). Indeed, culture media that 
allow a better inhibition of pathogens (MYA and CYA, respectively for F. verticillioides and F. 
graminearum) will be considered as resources for which microorganisms are in competition. Recently, 
Wei and collaborators showed that root-associated bacterial communities with a clear niche overlap 
with the pathogen reduce pathogen invasion success, constrain pathogen growth, and have lower 
levels of diseased plants in greenhouse experiments [38]. 
Concerning interactions between Poly and fusaria pathogens, Poly is one of the most 
competitive BCAs despite its high nutritional requirements. It is able to proliferate very rapidly under 
favorable conditions. Against the two pathogens, it will be able to invade the space left free more 
quickly, until it grows on the colonies of the pathogen. This behavior suggests an interaction 
requiring close contact, like parasitism. Poly is known for its capacities to colonize fungi and 
oomycetes [39]. The perception of the pathogen could be done via the perception of ergosterol from 
pathogens. In fact, sterols have been identified first as stimulating the sexual reproduction of Pythium 
species (like Poly) [40–42]. The same stimulation effects have been observed during dual culture 
bioassays with fungal pathogens [43]. This ability is a considerable advantage for the invasion of Poly 
and its mechanisms of action against pathogens. In addition to limiting the spatial spread of the 
pathogen, the absence of pathogenic pigment suggests a direct interaction with the metabolism of 
mycotoxigenic pathogens. At the same time after inoculation, compared to Xedavir, which has a 
slower progression, the contact took place in a very subtle manner. It seems that the BCA did not 
want to be perceived by the pathogens and only few wall degradation enzymes were synthesized. In 
dual culture bioassay against F. graminarum, Poly was able to pass through the mycelium of the 
pathogen and induce formation of lysed wall hyphae. They could be considered as privileged spaces 
for nutrient sampling by the BCA, suggesting again a close-contact interaction, such as 
mycoparasitism. These observations are entirely consistent with another study by Charlène Faure et 
al., who had observed the same type of behavior by Poly, capable of crossing the mycelium of F. 
graminearum without forming any particular structure [43]. During the antagonist activity test, Poly 
showed very good antagonistic capacities, allowing a reduction of the growth of both pathogens. 
However, the impact on mycotoxin production was much stronger on F. graminearum, against which 
it was particularly effective. By integrating the impact of the growing medium, Poly was the BCA 
that was most sensitive to change in nutritional resources. From the beginning of the study, it was 
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the microorganism that was the most sensitive to culture media, with an inability to produce oospores 
in vitro in synthetic culture media that are not enriched in sterols. In contrast, it was able to deploy 
its mechanisms of action during dual culture bioassays because it was stimulated by the presence of 
the pathogen and by the complex nutrients in the culture media. In fact, it was most effective on a 
culture medium composed mainly of cereals (OMA). The results showed that Poly was less adapted 
in terms of nutrient consumption than the pathogens on all the culture media of the dual culture 
bioassays, even on OMA, where it showed very strong antagonistic capacities during dual culture 
bioassay test. It would therefore appear that unlike Xeda, nutrient competition was not a preferential 
mechanism for Poly to deal with mycotoxigenic fungal pathogens. Nevertheless, it is interesting to 
note that threonine was a compound that was consumed only by Poly BCA and did not promote 
growth of other microorganisms, including the two mycotoxigenic pathogens. It was interesting to 
test the enrichment of commercial formulations with compounds of this type in order to boost the 
growth of Poly during treatment in real conditions.  
The three BCAs therefore have contrasting and complementary strategies, with different 
capacities to inhibit the propagation of pathogens. Their behavior was identical in one aspect: all 
inhibited the peak production of 15-ADON produced by F. graminearum (see Figure A2A). 15-ADON 
is a precursor to the formation of DON [44]. This inhibition could therefore be a sign of an action on 
the biosynthesis pathway, in particular the Tri8 gene involved in the transformation of 15-ADON 
into DON.  
4. Conclusion 
In the present study, three commercial biological control agents (BCAs) were selected and tested 
to evaluate their antagonistic activities against F. graminearum and F. verticillioides, two mycotoxigenic 
fungi. Results suggest that this three BCAs revealed contrasting effects on growth and mycotoxin 
production of pathogens, particularly Xedavir® against F. verticillioides and Polyversum® against F. 
graminearum, the two most effective combinations. In addition, several paths could be explored 
concerning the various observed modes of action of these BCAs, like antibiosis, parasitism, or 
mycotoxin degradation. It would appear that the inhibition effect of BCAs could be dependent on the 
nutritional condition of interaction, providing new insight into the nutritional phenotype and 
potential competition between micro-organisms. Given the high levels of inhibition observed, further 
studies on the modes of action of these BCAs could be conducted, for example on synthesis of anti-
germinative compounds by Mycostop®, chitinolytic activities or by-products of microbial 
detoxification of mycotoxins by Xedavir®, or mycophageous action by Polyversum®. 
5. Material and Methods 
5.1. Micro-organisms 
5.1.1. Fusarium Species 
F. graminearum isolate BRFM 1967 and F. verticillioides isolate BRFM 2251 were used (CIRM, 
University of Aix-Marseille, Marseille, France), and chosen for their strong ability to produce their 
respective mycotoxins. F. graminearum strain BRFM 1967, isolated from wheat plant, has a 
deoxynivalenol (DON/15-ADON) chemotype profile, while F. verticillioides BRFM 2251, isolated from 
maize kernels, has a fumonisins (FB1/FB2/FB3) chemotype profile. All fungi were maintained on 
potato dextrose agar (PDA; BD Difco, Sparks, MA, USA) under paraffin oil at 4 °C and actively grown 
on PDA at 25 °C for 7 days for spore production. 
5.1.2. Commercial Biological Control Agents (BCAs)  
Three commercial biological control agents were selected for their contrasting characteristics. To 
date, there is little information on their action and biocontrol mechanisms on mycotoxigenic fungi 
(Table 2). 
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All strains were isolated from their commercial product with a classical microbial insulation 
protocol (serial dilution and multiple striation inoculation), on appropriate medium (supplemented 
with 0.01% of tetracycline for Polyversum only). BCAs were conserved under spore forms in glycerol 
solution (15%/−80 °C) and in commercial product aliquots (4 °C). The strains were actively grown on 
ISP4, PDA, and V8, respectively, for Mycostop, Xedavir, and Polyversum at 25 °C for 7 days for spore 
production. For the rest of the study, the strains isolated from commercial products were referred to 
using the following abbreviations: Myco for Mycostop/S. griseoviridis, Xeda for Xedavir/T. asperellum, 
and Poly for Polyversum/P. oligandrum.  
Table 2. Contrasting characteristics of the selected commercial biocontrol agents. 
BCAs, Commercial 
Products 
Mycostop Xedavir Polyversum 
Strain 
Streptomyces griseoviridis 
strain K61 
Trichoderma 
asperellum strain 
TV1 
Pythium oligandrum 
strain M1/ATCC 
38472 
Family  Actinomycete  Ascomycete Pythiaceae 
Kingdom Bacteria Fungi Oomycete 
Plant/soil of isolation Sphagnum peat 
Root of tomato 
plant Sugar beet 
Locations of isolation Finland Italy Czechoslovakia 
Recommended Use General soil treatment General soil 
treatment 
Barley and wheat 
aerial treatment 
Target(s) Soil-borne pathogen 
Soil-borne 
pathogen 
Fusarium 
graminearum 
Commercialization 
company Lallemand Plant Care 
® 
Xeda International 
® DeSangosse 
® 
Date of marketing 2014 2013 2015 
Identified general 
mechanism of action  
Production of 
antimicrobial 
compound, 
mycoparasitism, plant 
defense induction 
Mycoparasitism, 
plant defense 
induction 
Mycoparasitism, 
plant defense 
induction 
/on mycotoxigenic 
fungi 
/none /none /on F. graminearum 
5.1.3. Behaviors on Different Media  
To identify the culture media best suited to the dual culture bioassay of each of the 
BCAs/pathogen, seven culture media candidates were chosen: PDA, Czapeck agar (CZA), Czapeck 
yeast agar (CYA), and oat meal agar (OMA) for their affinity with pathogens [45–48], and potato 
dextrose agar (PDA), International Streptomyces Project Medium 2 (ISP2), malt yeast agar (MYA), and 
corn meal agar (CMA) for their affinity with BCAs (respectively all BCAs, Myco [49,50], Xeda 
[13,51,52], and Poly [53–55]). The compositions of media are available in Figure A1. All isolates were 
inoculated at the center of Petri dishes (5 µL × 104 spores mL-1) and the growth kinetics were measured 
by image analysis on ImageJ software (area measurement in cm2/every two days for 8 days). 
Produced spores were evaluated by flooding the plates on the final day at the end of kinetics (after 8 
days) and counted under an optic microscope with Thoma cell. Mycotoxin analyses were performed 
for pathogen with the method described below (Section 5.2.2). 
This result was be used to select two culture media for each BCA/pathogen pair for the dual 
culture bioassay tests.  
5.2. Antagonist Activity in vitro on Selected Culture Media 
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5.2.1. Dual Culture Bioassay and Growth Evaluation 
On selected media (Table 1), one BCA and one pathogen were inoculated in a Petri dish, 85 mm 
in diameter, at the same distance from the center of plate. The pathogens and BCAs were inoculated 
with the spore suspension except for Poly, which was inoculated with 7-day plugs (5 mm in 
diameter). Each BCA was inoculated 24 h in advance (5 µL x 105 spores mL-1 or plug); then the 
pathogens were inoculated at the opposite side (45 mm from BCA, 5 µL × 104 spores.mL-1). Plates 
were incubated at 25 ± 2 °C, in the dark, for 12 days. Plates inoculated only with the pathogen were 
used as a control treatment. Every two days, Petri dish were photographed, and the colony area of 
each BCA/pathogen were measured in cm2 by image analysis using ImageJ software (1.52a, Wayne 
Rasband National Institute of Health, Bethesda, MD, USA, 2018). Values were used to create growth 
curves. Each BCA/pathogen dual culture bioassay and control was set up in triplicate for each 
analyzed day and two independent repetitions of the test were done. 
5.2.2. Mycotoxin Extraction and Analysis 
After growth evaluation, each dual culture bioassay plate was submitted to a mycotoxin 
analysis. The extraction procedure described by Moreau and Levi [56] was used with some 
modifications (no purification steps). For both pathogens, half a Petri dish was sampled by cutting 
along the line formed by the two inoculation points, and finely cut and weighed. For F. graminearum 
tests or controls, 50 mL of acetonitrile/water/acetic acid (79:20:1, v/v/v) were added. For F. verticillioides 
tests or controls, 150 mL of water/acetic acid (99.5:0.5, v/v/v) were added. All samples were 
homogenized by mechanical agitation for 20 min. F. graminearum samples were preliminarily diluted 
1:50 in water/acetic acid (99.5:0.5; mobile phase of analyzer) and filtered with a CA filter (0.45 µm, 
Carl Roth GmbH, Karlsruhe, Germany); F. verticillioides samples were directly filtered, and were 
ready for injection. 
For all samples, mycotoxin detection and quantification were achieved using an Ultra High-
Performance Liquid Chromatography (UHPLC, Shimadzu, Tokyo, Japan) coupled with a mass 
spectrometer (8040, Shimadzu, Tokyo, Japan). LC separation was performed using a Phenemenex 
Kinetex XB Column C18 (50 mm × 2 mm; 2.6 µm particles) at 50 °C, with an injection volume of 50 
µL. Mobile phase composition was (A) 0.5% acetic acid in ultra-pure water and (B) 0.5% acetic acid 
in isopropanol (HPLC MS grade, Sigma, St Louis, MO, USA), and the mobile phase flow rate was 0.4 
mL min-1. The mass spectrometer was operated in electrospray positive (ESI+) and negative (ESI–) 
ionization mode, and two multiple reaction monitoring (MRM) transitions for each analyte were 
monitored for quantification (Q) and qualification (q) (Table 3, Table 4). All data were analyzed using 
LabSolution Software (v5.91/2017, Shimadzu, Tokyo, Japan,2017). Limits of detection or 
quantification (LOD/LOQ in ng mL-1, respectively) for each mycotoxin were: DON (4/14), 15-ADON 
(10/35), FB1 (0.03/0.1), and FB2 (0.01/0.05). Mycotoxin levels were expressed in ng g-1 of medium or ng 
cm-2, respectively, for global and specific mycotoxin production. Values were used to create global 
and specific mycotoxin production curves. Each BCA/pathogen dual culture bioassay and control 
mycotoxin analysis was set up in triplicate for each measurement day, and two independent 
repetitions of the test were done. 
Table 3. MS/MS parameters for isotope-labelled internal standard (IS). MRM: multiple reaction 
monitoring. 
IS Polarity MRM EC 
DON C13 − 370.3 > 59.0 35 
FB1 C13 + 756.3 > 356.5 − 47 
 
  
Toxins 2020, 12, 152 16 of 22 
 
Table 4. MS/MS parameters for mycotoxins. Q: quantification; q: qualification. 
Mycotoxin Polarity MRM Q EC MRM Q MRM Q EC MRM Q R2 Calibration Curve IS 
Fumonisin B1 + 722.35 > 334.5 −43 722.35 > 352.0 −44 0.9982 FB1 C13 
Fumonisin B2 + 706.2 > 318.4 −37 706.2 > 3336.4 −44 0.9980 FB1 C13 
DON − 355.0 > 59.0 35 355.0 > 265.1 35 0.9998 DON C13 
5.3. Macroscopic and Microscopic Observations  
For the macroscopic observations, plates obtained in the same conditions described previously 
were used to identify for signs of an inhibition zone between each BCA/pathogen dual culture 
bioassay or/and the activation of secondary metabolism through the differential presence of pigments 
compared to the control or/and the BCA overgrowth on the pathogenic colony suggesting 
mycoparasite activity. The BCA control plates were added, with BCA alone in same conditions. 
Microscopic observations were performed with an adapted method from Reithner [57]. On glass 
slides, 1.5 mL of common medium (CM) for each BCA/pathogens pair (CYA for F. graminearum and 
PDA for F. verticillioides) were deposited, inoculated with BCA/pathogen pairs on opposite sides (4.5 
cm), incubated at 25 °C on supports in Petri dishes containing wet sterile filter paper, and sealed with 
parafilm. Glass slides inoculated only with pathogens were used as the control. The evolution of 
interaction was observed daily until 24 h after contact between BCAs and pathogens (120 h), with a 
Zeiss PrimoStar microscope. Pictures were taken using a Zeiss Axiocam ERc5s camera (Carl Zeiss 
Microscopy, Thornwood, NY, USA). The obtained pictures were treated with Photoshop CC Software 
(19.0, Adobe, San Jose, CA, USA, 2017), using the following pipe-line: contrast/light correction, filter 
layer correction, selection of a color/black and white density filter (reduces yellowing of color 
treatment, provides contrast for the microorganism contours), complementary manual selection of 
microorganisms, color filling (background transparency and Gaussian blur), and directional gradient 
in section. 
5.4. Nutrient Profiling  
Phenotype microarrays plates (Biolog, Hayward, CA, USA) were used for the nutrient profiling 
of all microorganisms according to the manufacturer’s instructions. For the carbon and nitrogen 
consumption profiling, PM1 and PM3 were used, respectively. Carbon sources in PM1 are in the 5–
50 mM range and nitrogen sources in PM3 are in the 2–20 mM range [58]. Inocula were suspended in 
sterile Biolog FF inoculating fluid and adjusted to a transmission of 81 and 62% at 590 nm for Myco 
and other micro-organisms, respectively. Plates were incubated in darkness at 25 °C, and growth 
(optical density) at 750 nm after 0, 12, 18, 24, 36, 42, 48, 60, 66, 72, 84, 90, 96, 114, and 138 h using an 
Enspire Multimode Reader (Perkin Elmer, Waltham, MA, USA) was monitored. The precise 
composition of all dual culture bioassay media was established in light of literature and confronted 
with the nutrient resources of plates. 
5.5. Data Expression and Statistical Analysis 
With the aim of considering complete growth and/or mycotoxin production kinetics, and not 
only a final point, the area under the growth/mycotoxin production curves were calculated for the 
antagonistic test and nutrient profiling test. 
Statistical data analysis was performed with R Software (3.4.4, R Foundation for Statistical 
Computing, Vienna, Austria, 2017). Normality and homogeneity of variances were checked with the 
Shapiro–Wilk test (with Holm–Bonferroni correction) and Levene’s test, respectively. For each 
pathogen, the effect of BCA treatments was tested with a one-way ANOVA and multiple 
comparisons of means were done with Tukey’s test (α = 0.05). For the principal component analysis 
(PCA), data were standardized, and the analysis was done on the correlation matrix with the 
FactoMine R package. The first two components were retained in both cases. For the visualization of 
specific differences between microorganisms nutrient profiling, the negative control was subtracted 
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and a heatmap was built with the ggplot package. The color scale indicates differential nutrient 
consumption in comparison with other micro-organisms (row comparison). 
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Appendix A 
Appendix A.1. Medium Composition 
 
Figure A1: Detailed composition of culture media. In all tables, principal ingredients for the 
preparation of media in laboratory are described. Trace element solutions (TES) were added after 
autoclaving the culture media. For complex ingredients, superscript numbers refer to the main 
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components in C and N identified through the literature. 1 Agar [59,60]. Major C components: 𝛃-D- 
galactopyrose, 𝛂-L-galactopyranose, agarobiose, agaropectine. Major N component: uronic acid. 2 
Yeast extract [60,61]. Major C component: mannitol. Major N components: alanine, lysine, aspartic 
acid, glutamic acid. 3 Potato infusion [62,63]. Major C component: starch (glucose + glucose), Major N 
components: asparagine, glutamine, aspartic acid. 4 Malt extract [60,64]. Major C components: 
maltose, glucose-fructose, dextrine, maltobiose. Major N components: glutamic acid, proline, alanine, 
leucine, phenylalanine. 5 Oatmeal [65–67]. Major C components: starch (glucose+glucose), 
arabinoxylane, 𝛃-glucan. Major N components: phenylalanine, tyrosine, leucine, valine, arginine, 
lysine, glutamic acid, glycine, alanine, serine. 
Appendix A.2. Kinetics of pathogen growth and mycotoxin inhibition in dual culture bioassay with BCAs 
(common media, CM) 
Figure A2: Comparative effects of BCA treatments on the evolution of pathogens. Dual culture 
bioassays for all BCAs against one pathogen were performed using common medium, CM. (A) F. 
A 
B 
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graminearum, on CYA, in orange; (B) F. verticillioides, on PDA, in pink, for 12 days. Growth (A1, B1) is 
expressed in cm2, and mycotoxin production levels (A2, A3, B2) are expressed in ng g-1 of media. FB1 
+ FB2 are represented together because the quantity of FB2 was not significant. ANOVA test, p-value 
< 0.05. 
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